International Stem Cell Corporation
ISCO
$0.51
$0.024.49%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.74% | -11.90% | 8.72% | 4.98% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.74% | -11.90% | 8.72% | 4.98% | 0.00% |
| Cost of Revenue | -3.83% | 7.68% | 7.60% | 1.53% | 11.84% |
| Gross Profit | 19.70% | -25.21% | 9.63% | 7.19% | -8.45% |
| SG&A Expenses | 19.74% | 10.93% | -3.52% | 0.42% | -6.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.87% | 3.05% | 0.26% | 4.49% | 1.60% |
| Operating Income | 11.63% | -713.73% | 204.44% | 12.08% | -20.79% |
| Income Before Tax | 14.06% | -3,263.64% | 145.60% | 8.40% | -19.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.06% | -3,263.64% | 145.60% | 8.40% | -19.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.06% | -3,263.64% | 145.60% | 8.40% | -19.63% |
| EBIT | 11.63% | -713.73% | 204.44% | 12.08% | -20.79% |
| EBITDA | 2.50% | -346.67% | 505.41% | 11.06% | -24.03% |
| EPS Basic | 14.06% | -3,207.14% | 123.08% | 9.09% | -19.85% |
| Normalized Basic EPS | 14.00% | -3,122.22% | 145.92% | 8.60% | -19.76% |
| EPS Diluted | 14.06% | -3,207.14% | 118.00% | 9.09% | -19.85% |
| Normalized Diluted EPS | 14.00% | -3,122.22% | 144.90% | 8.60% | -19.76% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 2.04% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |